3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Follicular
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma, Non-Hodgkin
10
Lymphoma
10
Lymphoma, Mantle-Cell
7
Recurrence
5
Lymphoma, B-Cell, Marginal Zone
5
Neoplasms
4
Lymphoma, B-Cell
4
Leukemia, B-Cell
3
Neoplasm, Residual
2
Burkitt Lymphoma
2
Mature B-Cell Malignancies
1
Lymphatic Diseases
1
Leukemia, Hairy Cell
1
Leukemia
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Cytokine Release Syndrome
1
Interventions
Cyclophosphamide
4
fludarabine phosphate
3
ibrutinib
2
fludarabine
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Mesna
2
Bone Marrow Transplantation
2
pirtobrutinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
Surveys and Questionnaires
1
Patient Reported Outcome Measures
1
Melphalan
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphoid
×
obinutuzumab
×
90 days
×
Clear all
No trials found.